
1. General Information
GENRYZON is a prescription growth-hormone replacement medicine containing somatrogon. Unlike conventional daily growth-hormone therapy, somatrogon is formulated for once-weekly subcutaneous administration. The 24 mg pre-filled pen contains 24 mg of somatrogon in 1.2 mL.
It should be used under the supervision of an appropriately qualified healthcare professional, particularly because the dose is individualized according to body weight and treatment response.
2. Product Information
- Brand: GENRYZON
- Active ingredient: Somatrogon
- Strength: 24 mg/1.2 mL
- Dosage form: Solution for injection
- Presentation: Pre-filled pen
- Route: Subcutaneous injection
- Typical frequency: Once weekly
- Manufacturer: Pfizer
- Indication: Pediatric growth hormone deficiency
- Approved age: Children and adolescents from 3 years of age with growth disturbance due to insufficient growth hormone secretion.
3. Uses of GENRYZON 24 mg Injection
GENRYZON is used for the treatment of growth disturbance associated with insufficient secretion of growth hormone in children and adolescents aged 3 years and older.
It should not be used simply for increasing height in individuals who do not have a medically diagnosed growth-hormone deficiency.
4. Benefits of GENRYZON
When prescribed for an appropriate patient with growth hormone deficiency, GENRYZON can:
- Support normal growth and linear height development.
- Help improve growth velocity in children with growth hormone deficiency.
- Provide growth-hormone replacement with once-weekly rather than daily injections.
- Offer a convenient pre-filled pen delivery system.
- Produce height outcomes comparable to daily growth hormone in studied pediatric patients.
5. Side Effects of GENRYZON
Like other growth-hormone therapies, GENRYZON can cause adverse effects. The prescribing physician should evaluate the individual patient's medical history and monitor treatment response.
Potential adverse effects may include:
- Injection-site reactions
- Headache
- Joint or muscle discomfort
- Swelling or fluid retention
- Rash
- Changes in glucose metabolism
- Reduced thyroid function in some patients
- Rarely, increased pressure inside the skull or other serious complications associated with growth-hormone therapy
The patient should contact their healthcare professional if persistent or severe symptoms develop.
6. Common Side Effects
Reported or clinically relevant side effects can include:
- Pain, redness, or swelling at the injection site
- Headache
- Fatigue
- Rash
- Joint pain
- Muscle pain
- Peripheral swelling
Injection-site reactions are among the commonly reported effects of somatrogon therapy.
7. How to Use GENRYZON
GENRYZON is administered subcutaneously once weekly, according to the dose prescribed by the physician. The recommended dose in the Indian product information is 0.66 mg/kg of body weight once weekly, with subsequent adjustment based on factors such as growth response, adverse reactions, body weight, and IGF-1 levels.
The injection may be administered into the:
- Abdomen
- Thighs
- Buttocks
- Upper arms
Injection sites should be rotated. Patients should receive appropriate training from a healthcare professional before self-administration.
Important: The 24 mg pen can deliver individual doses from 0.2 mg to 12 mg per injection. If a prescribed dose is greater than 12 mg, more than one injection may be required.
8. How GENRYZON Works
GENRYZON contains somatrogon, a long-acting recombinant human growth hormone analogue. It acts similarly to naturally occurring human growth hormone.
Somatrogon has been modified with three copies of naturally occurring C-terminal peptides (CTPs), which extend its circulation time in the body. This longer half-life enables once-weekly administration rather than conventional daily administration.
Growth hormone promotes growth and development partly through stimulation of insulin-like growth factor-1 (IGF-1) and related growth pathways.
9. Safety Advice
- Use GENRYZON only on prescription and under medical supervision.
- Do not change the dose or injection frequency without consulting the prescribing physician.
- Tell the doctor about diabetes, impaired glucose tolerance, thyroid disorders, previous malignancy, or other significant medical conditions before treatment.
- Regular monitoring may include growth response, IGF-1, blood glucose, and thyroid function when clinically appropriate.
- Rotate injection sites to reduce local reactions.
- Never reuse needles.
- GENRYZON should be stored in a refrigerator at 2–8°C and should not be frozen.
- Keep the medicine out of reach of children.
- Do not use the product if the solution appears unsuitable or the pen is damaged.
- Follow the official product instructions supplied with the pen.
10. FAQs
Q1. What is GENRYZON 24 mg?
GENRYZON 24 mg is a pre-filled pen containing somatrogon, a long-acting recombinant human growth hormone analogue used for pediatric growth hormone deficiency.
Q2. How often is GENRYZON administered?
It is generally administered once weekly, with the dose determined by the prescribing physician.
Q3. Who can use GENRYZON?
It is indicated for children and adolescents 3 years and older with growth disturbance caused by insufficient growth hormone secretion.
Q4. Is GENRYZON the same as somatropin?
No. GENRYZON contains somatrogon, a long-acting modified recombinant growth hormone analogue. Somatropin is recombinant human growth hormone generally used in formulations requiring more frequent administration.
Q5. Can GENRYZON be self-injected?
Self-administration may be possible after appropriate instruction and training from a healthcare professional.
Q6. How should GENRYZON be stored?
The product should generally be refrigerated at 2–8°C and must not be frozen.
Q7. Can I change the weekly injection day?
The manufacturer information states that the administration day can be changed when necessary provided there are more than 72 hours between two doses.
Q8. Does GENRYZON require a prescription?
Yes. Growth-hormone treatment should be initiated and monitored by an appropriately qualified healthcare professional.
11. Substitute for GENRYZON
There is no universal one-to-one substitute for GENRYZON. Alternative growth-hormone products may contain somatropin or other growth-hormone formulations, but the appropriate alternative depends on the patient's diagnosis, age, dose, treatment history, availability, and local regulatory approval.
Examples of medicines in the broader growth-hormone category include somatropin-based products. Switching from GENRYZON should only be done under the direction of an endocrinologist or other qualified prescriber.
12. SEO Keywords
- GENRYZON 24mg Injection exporter from India
- GENRYZON 24mg Injection supplier
- GENRYZON 24mg pre-filled pen
- GENRYZON Somatrogon 24mg
- Somatrogon 24mg Injection exporter
- Somatrogon growth hormone injection
- GENRYZON 24mg for growth hormone deficiency
- GENRYZON 24mg pediatric GHD treatment
- GENRYZON injection pharmaceutical exporter
- GENRYZON medicine exporter from Nagpur
- GENRYZON 24mg wholesale supplier India
- GENRYZON 24mg international pharmaceutical supplier
- GENRYZON 24mg export from India
- Somatrogon 24mg exporter India
- GENRYZON 24mg supplier USA
- GENRYZON 24mg supplier UK
- GENRYZON 24mg supplier Australia
- GENRYZON 24mg supplier Canada
- GENRYZON 24mg supplier Singapore
- GENRYZON 24mg supplier South Korea
- GENRYZON 24mg supplier UAE
- long acting growth hormone injection exporter
- once weekly growth hormone treatment
- pediatric growth hormone deficiency medicine
- recombinant human growth hormone analogue
- Pfizer GENRYZON 24mg pre-filled pen
- Somatrogon injection pharmaceutical supplier
- growth hormone deficiency medicine exporter India
- genuine GENRYZON 24mg pharmaceutical supply
- GENRYZON 24mg global medicine exporter
Keywords







